HOTH Valuation

Hoth Therapeutics Inc

Add to Watchlist

Advanced Chart

1.280

-0.02(-1.538%)1D

Overview
Forecast
Valuation
Earnings

HOTH Relative Valuation

HOTH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, HOTH is overvalued; if below, it's undervalued.

Historical Valuation

Hoth Therapeutics Inc (HOTH) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -1.80. The fair price of Hoth Therapeutics Inc (HOTH) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：1.28

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

1.46

P/B

Median3y

0.80

Median5y

1.65

-46.84

FCF Yield

Median3y

-135.68

Median5y

-97.35

Competitors Valuation Multiple

The average P/S ratio for HOTH's competitors is 6.34, providing a benchmark for relative valuation. Hoth Therapeutics Inc Corp (HOTH) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

HOTH.O

Hoth Therapeutics Inc

Loss

Average P/S: 6.34

16.91M